Armata Pharmaceuticals, Inc.

ARMP · AMEX
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$14,756$4,328$11,688$9,291
Short-Term Investments$0$0$0$0
Receivables$759$2,168$238$744
Inventory$0$0$0$0
Other Curr. Assets$1,415$1,024$1,240$1,273
Total Curr. Assets$16,930$7,520$13,166$11,308
Property Plant & Equip (Net)$52,477$53,161$53,973$54,928
Goodwill$3,490$3,490$3,490$3,490
Intangibles$10,256$10,256$10,256$10,256
Long-Term Investments$0$0$5,390$5,480
Tax Assets$0$0$0$0
Other NC Assets$6,363$6,363$975$975
Total NC Assets$72,586$73,270$74,084$75,129
Other Assets$0$0$0$0
Total Assets$89,516$80,790$87,250$86,437
Liabilities
Payables$1,280$965$981$766
Short-Term Debt$135,605$116,824$107,242$43,385
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$3,065$2,296$2,317$4,098
Total Curr. Liab.$139,950$120,085$110,540$48,249
LT Debt$42,077$27,131$27,416$83,130
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$3,077$3,077$3,077$3,077
Other NC Liab.$0$0$0$0
Total NC Liab.$45,154$30,208$30,493$86,207
Other Liabilities$0$0$0$0
Cap. Leases$31,362$31,619$31,875$32,125
Total Liabilities$185,104$150,293$141,033$134,456
Equity
Pref Stock$0$0$0$0
Common Stock$362$362$362$362
Retained Earnings-$377,236-$350,561-$334,266-$327,735
AOCI$0$0$0$0
Other Equity$281,286$280,696$280,121$279,354
Total Equity-$95,588-$69,503-$53,783-$48,019
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$89,516$80,790$87,250$86,437
Net Debt$162,926$139,627$122,970$117,224